{"id":"placebo-vaginal-ring","safety":{"commonSideEffects":[{"rate":null,"effect":"Vaginal irritation"},{"rate":null,"effect":"Device expulsion"},{"rate":null,"effect":"Vaginal discomfort"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo vaginal rings are non-medicated devices used in contraceptive and hormone therapy clinical trials to maintain blinding and assess the effect of the ring formulation itself versus active drug. They are inserted into the vagina and remain in place for a specified duration, identical in appearance and handling to active formulations but without therapeutic agents.","oneSentence":"A placebo vaginal ring delivers no active pharmaceutical ingredient and serves as an inert control device for clinical trials.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:01:34.875Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Placebo control in clinical trials for vaginal ring contraceptives and hormone replacement therapies"}]},"trialDetails":[{"nctId":"NCT02518594","phase":"PHASE3","title":"A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix","status":"COMPLETED","sponsor":"The George Washington University Biostatistics Center","startDate":"2015-11-13","conditions":"Short Cervical Length","enrollment":1311},{"nctId":"NCT05317364","phase":"PHASE4","title":"Topical Vaginal Estrogen for Postpartum Obstetric Anal Sphincter Injury Recovery","status":"TERMINATED","sponsor":"University of Alabama at Birmingham","startDate":"2022-07-14","conditions":"Obstetric; Injury Pelvic Floor, Sexual Dysfunction, Anal Incontinence","enrollment":38},{"nctId":"NCT07330375","phase":"PHASE3","title":"Effect of Intravenous Dexmedetomidine and Ketamine on Post-Operative Analgesia","status":"NOT_YET_RECRUITING","sponsor":"Zagazig University","startDate":"2026-01-20","conditions":"Postoperative Analgesia, Postoperative Pain Management","enrollment":50},{"nctId":"NCT07083635","phase":"PHASE2","title":"Transdermal Ethinyl Estradiol and Norelgestromin for Irregular Bleeding in Contraceptive Implant Users","status":"RECRUITING","sponsor":"Chulalongkorn University","startDate":"2025-07-29","conditions":"Menstruation Disturbances, Metrorrhagia, Uterine Hemorrhage","enrollment":40},{"nctId":"NCT07178379","phase":"NA","title":"Hysteroscopy Anesthesia for Relief of Pain","status":"NOT_YET_RECRUITING","sponsor":"Maimónides Biomedical Research Institute of Córdoba","startDate":"2025-09-06","conditions":"Pain Management, Outpatient Hysteroscopy, Local Anesthesia","enrollment":70},{"nctId":"NCT07160855","phase":"PHASE4","title":"Letrozole Plus Misoprostol Versus Misoprostol Alone for Treating Women With Missed Miscarriage","status":"RECRUITING","sponsor":"Nishtar Medical University","startDate":"2025-05-13","conditions":"Miscarriage in First Trimester, Missed Miscarriage","enrollment":92},{"nctId":"NCT04046900","phase":"PHASE1, PHASE2","title":"Vaginal Microbiota Transplant","status":"RECRUITING","sponsor":"Douglas Kwon","startDate":"2021-04-22","conditions":"Recurrent Bacterial Vaginosis","enrollment":62},{"nctId":"NCT06508944","phase":"PHASE4","title":"Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2024-04-08","conditions":"Lower Urinary Tract Symptoms, Female Genitourinary Disease, Urinary Stress Incontinence","enrollment":86},{"nctId":"NCT06135974","phase":"EARLY_PHASE1","title":"Vaginal lIve Biotherapeutic RANdomized Trial","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2024-02-01","conditions":"Bacterial Vaginosis","enrollment":24},{"nctId":"NCT06163274","phase":"EARLY_PHASE1","title":"Trial to Assess Acceptability and Safety of Two Placebo Intravaginal Rings","status":"TERMINATED","sponsor":"University of Pittsburgh","startDate":"2024-02-28","conditions":"Safety, Acceptability","enrollment":93},{"nctId":"NCT06659380","phase":"NA","title":"Probiotic Efficacy in Postmenopausal Women with Bacterial Vaginosis","status":"RECRUITING","sponsor":"Hasanuddin University","startDate":"2024-06-26","conditions":"Bacterial Vaginosis (BV), Menopause","enrollment":12},{"nctId":"NCT04982692","phase":"PHASE3","title":"A Clinical Study of INTRAROSA® (Prasterone) Vaginal Inserts in Postmenopausal Vulvovaginal Atrophy","status":"COMPLETED","sponsor":"Lee's Pharmaceutical Limited","startDate":"2021-09-13","conditions":"Postmenopausal Vulvovaginal Atrophy","enrollment":417},{"nctId":"NCT06616077","phase":"EARLY_PHASE1","title":"Endometrial Transcript Profile with Progesterone After Post-ovulatory Mifepristone","status":"COMPLETED","sponsor":"Reproductive Health Research Insritute, Chile","startDate":"2022-06-07","conditions":"Endometrial Endocrine Regulation, Progesterone Supplementation in Women After Mifepristone","enrollment":9},{"nctId":"NCT01938092","phase":"PHASE2","title":"Vaginal Diazepam for the Treatment of Female Pelvic Pain","status":"COMPLETED","sponsor":"Raymond Foster","startDate":"2013-09","conditions":"Pelvic Floor Disorders, Pelvic Pain","enrollment":50},{"nctId":"NCT03544606","phase":"PHASE4","title":"Nitric Oxide Donor Isosorbide Mono Nitrate for Cervical Ripening in Induction of Labor","status":"COMPLETED","sponsor":"ahmed nagy shaker ramadan","startDate":"2023-12-01","conditions":"Induction of Labor Affected Fetus / Newborn","enrollment":160},{"nctId":"NCT05221021","phase":"PHASE4","title":"Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome","status":"RECRUITING","sponsor":"Walter Reed National Military Medical Center","startDate":"2022-10-01","conditions":"Overactive Bladder Syndrome","enrollment":152},{"nctId":"NCT02668783","phase":"PHASE3","title":"Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2016-02-11","conditions":"Moderate to Severe Primary Dysmenorrhea","enrollment":25},{"nctId":"NCT01670656","phase":"PHASE2","title":"A Study to Evaluate the Effect of Contraceptive Vaginal Rings on Primary Dysmenorrhea (P08257/MK-8175A/MK-8342B-057)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2013-01-21","conditions":"Dysmenorrhea","enrollment":439},{"nctId":"NCT02668822","phase":"PHASE3","title":"Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in the Treatment of Women With Primary Dysmenorrhea (MK-8342B-060)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2016-02-09","conditions":"Dysmenorrhea","enrollment":18},{"nctId":"NCT02275546","phase":"PHASE3","title":"Performance and Safety of Vaginal Ring Applicator in Healthy Females (MK-8342A-063)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2014-12-11","conditions":"Contraception: Optional Applicator for Insertion of Vaginal Ring","enrollment":164},{"nctId":"NCT05617820","phase":"PHASE3","title":"Study Comparing Estradiol Vaginal Inserts 4mcg To IMVEXXY ® (Estradiol Vaginal Inerts 4 mcg) In The Treatment Of Dyspareunia in Women With Vulvur and Vaginal Atrophy","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2022-11-15","conditions":"Dyspareunia","enrollment":1050},{"nctId":"NCT04573504","phase":"PHASE4","title":"Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2020-09-23","conditions":"Vaginal Laceration During Delivery","enrollment":274},{"nctId":"NCT03692403","phase":"PHASE2","title":"Randomized Trial Assessing Quinagolide Vaginal Ring for Endometriosis-related Pain","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2018-12-26","conditions":"Endometriosis-related Pain","enrollment":22},{"nctId":"NCT03749109","phase":"PHASE2","title":"Quinagolide Vaginal Ring on Lesion Reduction Assessed by MRI in Women With Endometriosis/Adenomyosis","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2019-08-19","conditions":"Endometriosis","enrollment":67},{"nctId":"NCT05166746","phase":"PHASE2","title":"The Effect of Clindamycin and a Live Biotherapeutic on the Reproductive Outcomes of IVF Patients With Abnormal Vaginal Microbiota","status":"UNKNOWN","sponsor":"Peter Humaidan","startDate":"2017-12-07","conditions":"Bacterial Vaginoses, Infertility, Female","enrollment":333},{"nctId":"NCT05840328","phase":"PHASE4","title":"DEXMEDETOMIDINE in NORMAL VAGINAL DELIVERY","status":"UNKNOWN","sponsor":"Menoufia University","startDate":"2022-12-05","conditions":"Painless Vainal Labour","enrollment":60},{"nctId":"NCT00802646","phase":"NA","title":"The Effects of Combined Spinal Epidurals on Fever During Labor of First-Time Mothers","status":"WITHDRAWN","sponsor":"Ochsner Health System","startDate":"2009-06","conditions":"Vaginal Delivery","enrollment":""},{"nctId":"NCT00001259","phase":"PHASE1","title":"A Treatment Study for Premenstrual Syndrome (PMS)","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"1992-08-11","conditions":"Premenstrual Syndrome, Menstruation Disturbances","enrollment":60},{"nctId":"NCT02430233","phase":"PHASE4","title":"Vaginal Progesterone for the Prolongation of Pregnancy After Arrested Pre-term Labor","status":"COMPLETED","sponsor":"HaEmek Medical Center, Israel","startDate":"2018-12-19","conditions":"Preterm Labor","enrollment":129},{"nctId":"NCT01448616","phase":"PHASE4","title":"Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding","status":"COMPLETED","sponsor":"University of Washington","startDate":"2012-02","conditions":"Herpes Simplex Type II","enrollment":73},{"nctId":"NCT01617096","phase":"PHASE3","title":"Phase 3 Safety and Effectiveness Trial of Dapivirine Vaginal Ring for Prevention of HIV-1 in Women","status":"COMPLETED","sponsor":"International Partnership for Microbicides, Inc.","startDate":"2012-07-24","conditions":"HIV Infections","enrollment":2629},{"nctId":"NCT02010593","phase":"PHASE2","title":"Safety and Pharmacokinetics of Dapivirine Vaginal Ring in Post-menopausal Women","status":"COMPLETED","sponsor":"International Partnership for Microbicides, Inc.","startDate":"2013-12","conditions":"Human Immunodeficiency Virus","enrollment":96},{"nctId":"NCT02028338","phase":"PHASE2","title":"Study of Dapivirine Vaginal Ring (VR) in Adolescents","status":"COMPLETED","sponsor":"International Partnership for Microbicides, Inc.","startDate":"2014-06-27","conditions":"Human Immunodeficiency Virus","enrollment":96},{"nctId":"NCT01539226","phase":"NA","title":"Safety and Efficacy Trial of a Dapivirine Vaginal Matrix Ring in Healthy HIV-Negative Women","status":"COMPLETED","sponsor":"International Partnership for Microbicides, Inc.","startDate":"2012-03-27","conditions":"HIV Infections","enrollment":1959},{"nctId":"NCT00160173","phase":"PHASE4","title":"Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy","status":"COMPLETED","sponsor":"ASCEND Therapeutics","startDate":"2004-12-02","conditions":"Postmenopausal Symptoms","enrollment":221},{"nctId":"NCT02195986","phase":"PHASE3","title":"A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2014-06","conditions":"Atrophic Vaginitis","enrollment":366},{"nctId":"NCT00431093","phase":"PHASE4","title":"Trial to Compare the Effects of Tibolone (Livial®) and Continuous Combined Low-Dose Estradiol/Noresterone (Activelle®)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-11","conditions":"Menopause","enrollment":570},{"nctId":"NCT04500470","phase":"NA","title":"Ketoprofen With or Without Vaginal Isonicotinic Acid Hydrazide Prior to Hysterosalpingography","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2020-09-01","conditions":"Infertility, Female","enrollment":200},{"nctId":"NCT03493126","phase":"PHASE4","title":"Vaginal Estrogen on Postpartum Atrophy, Perineal Pain, and Sexual Function","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2018-10-15","conditions":"Vaginal Atrophy","enrollment":59},{"nctId":"NCT02995694","phase":"PHASE3","title":"A Study Comparing Estradiol Vaginal Cream to Estrace® Cream in Females With Atrophic Vaginitis","status":"COMPLETED","sponsor":"Alvogen Pine Brook LLC","startDate":"2016-03","conditions":"Atrophic Vaginitis","enrollment":535},{"nctId":"NCT00705679","phase":"PHASE2","title":"Safety and Effectiveness of TFV 1% Gel, TDF Tablets, and FTC/TDF Tablets in Preventing HIV in Women","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2009-08","conditions":"HIV Infections","enrollment":5029},{"nctId":"NCT04500522","phase":"PHASE4","title":"Vaginal Isonicotinic Acid Hydrazide Prior to Diagnostic Office Hysteroscopy in Primarily Infertile Patients","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2020-09-01","conditions":"Infertility, Female","enrollment":150},{"nctId":"NCT04499989","phase":"PHASE4","title":"Vaginal Isonicotinic Acid Hydrazide (INH) Administration Prior to T380A Intrauterine Device Insertion","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2020-09-01","conditions":"IUCD Complication","enrollment":220},{"nctId":"NCT04159493","phase":"PHASE2","title":"A Randomized Controlled Phase 2 Study to Determine Lowest Efficacious Dose of Ovestin in Vulvar and Vaginal Atrophy","status":"WITHDRAWN","sponsor":"Aspen USA Inc","startDate":"2021-06-05","conditions":"Vaginal Atrophy","enrollment":""},{"nctId":"NCT04898556","phase":"PHASE3","title":"Clinical Study to Evaluate the Efficacy of Prasterone Treatment for Atrophy Vulvovaginal in Postmenopausal Women With Vulvar / Vestibular Pain","status":"UNKNOWN","sponsor":"Dr. Santiago Palacios","startDate":"2020-12-22","conditions":"Vulvovaginal Atrophy","enrollment":50},{"nctId":"NCT03338400","phase":"PHASE2","title":"Dexamethasone Administration To Improve Patient Recovery In Ambulatory Vaginal Prolapse Surgery: Is There A Role?","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2017-05-01","conditions":"Quality of Recovery, Same Day Surgery, Nausea and Vomiting, Postoperative","enrollment":51},{"nctId":"NCT03287232","phase":"PHASE3","title":"Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)","status":"COMPLETED","sponsor":"EndoCeutics Inc.","startDate":"2017-10-16","conditions":"Hypoactive Sexual Desire Disorder","enrollment":653},{"nctId":"NCT02620904","phase":"PHASE4","title":"Mifepristone Induction for Fetal Demise","status":"TERMINATED","sponsor":"Montefiore Medical Center","startDate":"2016-07-14","conditions":"Intrauterine Fetal Demise, Fetal Death","enrollment":9},{"nctId":"NCT03677336","phase":"PHASE4","title":"Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI","status":"COMPLETED","sponsor":"CRG UZ Brussel","startDate":"2019-05-01","conditions":"Infertility, Female, Infertility, Genital Diseases, Male","enrollment":30},{"nctId":"NCT04574999","phase":"PHASE3","title":"Study to Determine Efficacy & Safety of a Low Concentration Estriol (0.005%) in Postmenopausal Vaginal Atrophy.","status":"COMPLETED","sponsor":"Italfarmaco S.A","startDate":"2008-01-25","conditions":"Vaginal Atrophy","enrollment":167},{"nctId":"NCT04590482","phase":"PHASE4","title":"Letrozole Pretreatment With Misoprostol Induction of Abortion in First Trimester Missed Abortion","status":"UNKNOWN","sponsor":"Shereen Rady Abou El-fetouh","startDate":"2020-11-15","conditions":"Missed Abortion","enrollment":110},{"nctId":"NCT03464552","phase":"PHASE4","title":"Celecoxib in Colposcopic Directed Biopsy","status":"COMPLETED","sponsor":"Cairo University","startDate":"2018-04-15","conditions":"Colposcopy","enrollment":170},{"nctId":"NCT01958073","phase":"PHASE4","title":"Vaginal Estrogen for the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2013-10","conditions":"Recurrent Urinary Tract Infection","enrollment":35},{"nctId":"NCT03211156","phase":"PHASE2","title":"Treatment of Gardnerella Vaginalis Vaginal Colonization With Amoxicillin","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2017-09-11","conditions":"Vaginitis Gardnerella","enrollment":97},{"nctId":"NCT04499976","phase":"PHASE4","title":"Isonicotinic Acid Hydrazide Pretreatment With Misoprostol Induction of Abortion in First-trimester Missed Miscarriage","status":"UNKNOWN","sponsor":"Aswan University Hospital","startDate":"2020-09-01","conditions":"Abortion, Missed","enrollment":240},{"nctId":"NCT03740945","phase":"PHASE3","title":"Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer","status":"WITHDRAWN","sponsor":"EndoCeutics Inc.","startDate":"2018-11-06","conditions":"Vaginal Atrophy in Breast Cancer Patients","enrollment":""},{"nctId":"NCT03619005","phase":"PHASE3","title":"Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second Study","status":"WITHDRAWN","sponsor":"EndoCeutics Inc.","startDate":"2018-11-13","conditions":"Hypoactive Sexual Desire Disorder (HSDD)","enrollment":""},{"nctId":"NCT03665779","phase":"PHASE3","title":"Nitric Oxide Donor Isosorbide Mono Nitrate for Induction of Labor With Pre-labor Rupture of Membranes","status":"COMPLETED","sponsor":"ahmed nagy shaker ramadan","startDate":"2018-08-01","conditions":"Induction of Labor Affected Fetus / Newborn, Rupture of Membranes Prior to Onset of Labor","enrollment":140},{"nctId":"NCT02697331","phase":"PHASE3","title":"Vaginal Progesterone in Twin With Short Cervix","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2016-04-05","conditions":"Preterm Birth, Twin Dichorionic Diamniotic Placenta","enrollment":144},{"nctId":"NCT04393194","phase":"PHASE4","title":"The Effect of Intra-vaginal Conjugated Estrogen Cream on Ring Pessary Use for Pelvic Organ Prolapse","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2020-05-24","conditions":"Pelvic Floor Prolapse","enrollment":420},{"nctId":"NCT03065660","phase":"PHASE3","title":"Mifepristone and Misoprostol Versus Misoprostol Alone in the Medical Management of Missed Miscarriage","status":"COMPLETED","sponsor":"University of Birmingham","startDate":"2017-09-20","conditions":"Missed Miscarriage","enrollment":711},{"nctId":"NCT02367833","phase":"PHASE4","title":"Effects of Oral vs. Non-oral Contraceptives on the GH/IGF-1 Axis","status":"COMPLETED","sponsor":"Penn State University","startDate":"2015-01","conditions":"Bone; Disorder, Development and Growth","enrollment":60},{"nctId":"NCT03040011","phase":"PHASE1, PHASE2","title":"Preoperative Levator Ani Muscle Injection and Pudendal Nerve Block for Pain Control After Vaginal Reconstructive Surgery","status":"COMPLETED","sponsor":"Lauren Giugale, MD","startDate":"2017-06-01","conditions":"Pelvic Organ Prolapse, Surgery, Postoperative Pain","enrollment":79},{"nctId":"NCT02766023","phase":"PHASE2","title":"LACTIN-V Study for Recurrent Bacterial Vaginosis","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-06-03","conditions":"Bacterial Vaginosis","enrollment":228},{"nctId":"NCT03336437","phase":"PHASE4","title":"Estrogen and the Urogenital Microbiome in GSM","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2018-02-01","conditions":"Menopause","enrollment":40},{"nctId":"NCT02967510","phase":"PHASE2","title":"Study Evaluating the Efficacy and Safety of Three Formulations of Ultra-low Dose Estriol Vaginal Gel (0.005%, 0.002%, 0.0008% Estriol Vaginal Gel) for the Treatment of Vaginal Dryness in Postmenopausal Women With Vulvovaginal Atrophy","status":"COMPLETED","sponsor":"ITF Research Pharma, S.L.U.","startDate":"2016-10","conditions":"Vaginal Atrophy","enrollment":283},{"nctId":"NCT01618058","phase":"","title":"Observational Study of HIV Infection in Participants of Seroconvert During Dapivirine Vaginal Ring Trials","status":"COMPLETED","sponsor":"International Partnership for Microbicides, Inc.","startDate":"2012-10-04","conditions":"HIV Infections","enrollment":151},{"nctId":"NCT02413008","phase":"PHASE2","title":"A Clinical Trial to Assess the Safety of 0.005 % Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women With Early Stage Breast Cancer in Treatment With Aromatase Inhibitor in the Adjuvant Setting","status":"COMPLETED","sponsor":"ITF Research Pharma, S.L.U.","startDate":"2015-10-16","conditions":"Vaginal Atrophy","enrollment":61},{"nctId":"NCT02237950","phase":"PHASE3","title":"Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)","status":"COMPLETED","sponsor":"Starpharma Pty Ltd","startDate":"2014-10-13","conditions":"Bacterial Vaginosis","enrollment":586},{"nctId":"NCT02255045","phase":"PHASE2, PHASE3","title":"Assessment of a Vaginal Ring With Meloxicam in the Treatment of Dysmenorrhea","status":"COMPLETED","sponsor":"Laboratorios Andromaco S.A.","startDate":"2014-06-27","conditions":"Dysmenorrhea","enrollment":68},{"nctId":"NCT03917134","phase":"NA","title":"Prevention of Vaginal Cellulitis or Vaginal Cuff Abscess After Laparoscopic Hysterectomy","status":"UNKNOWN","sponsor":"CES University","startDate":"2019-05-01","conditions":"Hysterectomy, Cellulitis, Vaginosis","enrollment":600},{"nctId":"NCT03854175","phase":"NA","title":"Effect of Vaginal Sildenafil Citrate on Endometrial Preparation and Outcome in Frozen Thawed Embryo Transfer Cycles","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2019-02","conditions":"Infertility","enrollment":80},{"nctId":"NCT03781674","phase":"NA","title":"Role of 200 mg Versus 400mg Vaginal Progesterone in Prevention of Preterm Labor in Twin Gestation","status":"UNKNOWN","sponsor":"Aswan University Hospital","startDate":"2019-01-01","conditions":"Twin; Pregnancy, Affecting Fetus or Newborn","enrollment":200},{"nctId":"NCT03832894","phase":"PHASE3","title":"Oestradiol Supplementation in Luteal Long Agonist Fresh In Vitro Fertilization/Intra Cytoplasmic Sperm Injection ( IVF/ICSI) Cycle .","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2018-12-01","conditions":"Infertility","enrollment":2},{"nctId":"NCT01376349","phase":"PHASE3","title":"Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2011-07","conditions":"Breast Cancer, Gynecologic Cancer","enrollment":464},{"nctId":"NCT03782480","phase":"PHASE3","title":"Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy","status":"UNKNOWN","sponsor":"Center for Vulvovaginal Disorders","startDate":"2019-03-02","conditions":"Menopause, Genitourinary Syndrome of Menopause, Vulvovaginal Atrophy","enrollment":40},{"nctId":"NCT01753102","phase":"PHASE3","title":"Efficacy and Safety Of Spil's Estradiol Vaginal Tablet","status":"TERMINATED","sponsor":"Sun Pharmaceutical Industries Limited","startDate":"2012-11-06","conditions":"Vulvar Atrophy, Vaginal Atrophy","enrollment":49},{"nctId":"NCT03628625","phase":"PHASE2","title":"Letrozole Pretreatment With Misoprostol fInduction of Abortion In First-Trimester Missed Miscarriage","status":"UNKNOWN","sponsor":"Ain Shams Maternity Hospital","startDate":"2018-09-10","conditions":"Miscarriage, Missed Abortion","enrollment":80},{"nctId":"NCT02006264","phase":"PHASE1","title":"Safety and Pharmacokinetics (PK) of a Polyurethane Tenofovir Disoproxil Fumarate (TDF) Vaginal Ring","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2013-11-19","conditions":"HIV","enrollment":30},{"nctId":"NCT02762617","phase":"PHASE1","title":"Safety and Pharmacokinetics (PK) of a Polyurethane Tenofovir Disoproxil Fumarate (TDF) Vaginal Ring (TDF IVR-002)","status":"TERMINATED","sponsor":"Marla Keller","startDate":"2017-02-24","conditions":"Healthy, HIV","enrollment":17},{"nctId":"NCT02516202","phase":"PHASE3","title":"The Vaginal Health Trial","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2016-04","conditions":"Atrophy of Vagina, Menopause, Dyspareunia (Female)","enrollment":302},{"nctId":"NCT02236156","phase":"PHASE3","title":"Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)","status":"COMPLETED","sponsor":"Starpharma Pty Ltd","startDate":"2014-10-03","conditions":"Bacterial Vaginosis","enrollment":637},{"nctId":"NCT03427216","phase":"NA","title":"Baclofen/Diazepam Supps for Treatment of Pelvic Floor Myalgia","status":"UNKNOWN","sponsor":"Dr. John A. Thiel Medical Professional Corporation","startDate":"2018-09-01","conditions":"Pelvic Floor Dyssynergia","enrollment":60},{"nctId":"NCT01269450","phase":"NA","title":"Progesterone and Second Trimester Bleeding","status":"TERMINATED","sponsor":"HaEmek Medical Center, Israel","startDate":"2011-03","conditions":"Antepartum Bleeding, Preterm Birth","enrollment":128},{"nctId":"NCT02602366","phase":"NA","title":"The Quatro Study: Acceptability Study of (Placebo) Vaginal Delivery Forms for Preventing HIV and Unintended Pregnancy","status":"COMPLETED","sponsor":"CONRAD","startDate":"2016-06-06","conditions":"HIV, Contraception","enrollment":422},{"nctId":"NCT01755741","phase":"PHASE1","title":"Functionality of Male Condoms With a Silicone Elastomer Vaginal RIng","status":"COMPLETED","sponsor":"International Partnership for Microbicides, Inc.","startDate":"2013-02","conditions":"Human Immunodeficiency Virus","enrollment":70},{"nctId":"NCT03475160","phase":"NA","title":"Sildenafil Citrate and Recurrent Abortion","status":"COMPLETED","sponsor":"Benha University","startDate":"2015-12-01","conditions":"Recurrent Abortion","enrollment":130},{"nctId":"NCT02668796","phase":"PHASE3","title":"To Study Generic Estradiol 10 mcg Vaginal Tablets in the Treatment of Vulvar and Vaginal Atrophy in Post Menopausal Women.","status":"COMPLETED","sponsor":"Glenmark Pharmaceuticals Ltd. India","startDate":"2016-01","conditions":"Vulvar and Vaginal Atrophy","enrollment":522},{"nctId":"NCT01755754","phase":"PHASE1","title":"A Trial to Assess the Functionality of Female Condom With a Silicone Elastomer Vaginal Ring","status":"COMPLETED","sponsor":"International Partnership for Microbicides, Inc.","startDate":"2013-08","conditions":"Human Immunodeficiency Virus","enrollment":160},{"nctId":"NCT01689597","phase":"PHASE4","title":"Epidural Morphine for Analgesia After Traumatic Vaginal Delivery","status":"WITHDRAWN","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2012-09","conditions":"Traumatic Vaginal Delivery","enrollment":""},{"nctId":"NCT02920827","phase":"PHASE1","title":"Safety and Pharmacokinetic Trial in Healthy HIV-Negative Women to Assess the Delivery of Dapivirine From a Vaginal Ring","status":"COMPLETED","sponsor":"International Partnership for Microbicides, Inc.","startDate":"2009-08","conditions":"HIV Infections","enrollment":16},{"nctId":"NCT01846442","phase":"PHASE3","title":"Topical DHEA Against Vaginal Atrophy","status":"COMPLETED","sponsor":"EndoCeutics Inc.","startDate":"2007-06","conditions":"Vaginal Atrophy","enrollment":218},{"nctId":"NCT01256684","phase":"PHASE3","title":"DHEA Against Vaginal Atrophy - 3-Month Efficacy Study","status":"COMPLETED","sponsor":"EndoCeutics Inc.","startDate":"2010-12","conditions":"Vaginal Atrophy","enrollment":255},{"nctId":"NCT01358760","phase":"PHASE3","title":"Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy","status":"COMPLETED","sponsor":"EndoCeutics Inc.","startDate":"2011-06","conditions":"Vaginal Atrophy","enrollment":450},{"nctId":"NCT02013544","phase":"PHASE3","title":"Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause","status":"COMPLETED","sponsor":"EndoCeutics Inc.","startDate":"2014-02","conditions":"Vaginal Atrophy","enrollment":558},{"nctId":"NCT02253173","phase":"PHASE3","title":"Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women","status":"COMPLETED","sponsor":"TherapeuticsMD","startDate":"2014-09","conditions":"Vulvovaginal Atrophy, Menopause, Dyspareunia","enrollment":764},{"nctId":"NCT00429806","phase":"PHASE1","title":"DHEA Bioavailability Following Administration of Vaginal Suppositories in Post-Menopausal Women With Vaginal Atrophy","status":"COMPLETED","sponsor":"CHU de Quebec-Universite Laval","startDate":"2006-11","conditions":"Vaginal Atrophy","enrollment":40},{"nctId":"NCT00946088","phase":"PHASE2, PHASE3","title":"Progesterone for Maintenance Tocolysis: A Randomized Placebo Controlled Trial","status":"TERMINATED","sponsor":"Stanford University","startDate":"2009-10","conditions":"Pregnancy Complications","enrollment":7},{"nctId":"NCT00108849","phase":"PHASE3","title":"Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2005-03","conditions":"Menopause, Postmenopausal Vaginal Atrophy","enrollment":309},{"nctId":"NCT02720783","phase":"PHASE1","title":"Tolerability and Pharmacokinetic Study of Econazole Nitrate Plus Benzydamine HCl Vaginal Pessary","status":"COMPLETED","sponsor":"Aziende Chimiche Riunite Angelini Francesco S.p.A","startDate":"2016-03-04","conditions":"Healthy Women","enrollment":49}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":13,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["NuvaRing"],"phase":"marketed","status":"active","brandName":"Placebo vaginal ring","genericName":"Placebo vaginal ring","companyName":"Organon and Co","companyId":"organon-and-co","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo vaginal ring delivers no active pharmaceutical ingredient and serves as an inert control device for clinical trials. Used for Placebo control in clinical trials for vaginal ring contraceptives and hormone replacement therapies.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":4,"withResults":3},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}